FDA Advisory Panel To Discuss Vaccines Made From Human Tumor Cell Lines
This article was originally published in The Pink Sheet Daily
Executive Summary
The Sept. 19 meeting of FDA’s Vaccines and Related Biological Products Advisory Committee comes as several whole-cell cancer vaccines are in Phase III trials.